BMC Ophthalmology

Scope & Guideline

Innovating Ophthalmology Through Open Access Research

Introduction

Welcome to your portal for understanding BMC Ophthalmology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationBMC OPHTHALMOL / BMC Ophthalmol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

BMC Ophthalmology is dedicated to advancing the field of ophthalmology through the dissemination of high-quality research. The journal's primary focus encompasses a wide range of topics related to eye health, visual function, and innovative treatment methodologies, aiming to improve patient outcomes and enhance our understanding of ocular diseases.
  1. Clinical Research in Ophthalmology:
    The journal emphasizes clinical studies that investigate the effectiveness of various treatments and surgical techniques for ocular conditions, including cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration.
  2. Innovative Surgical Techniques:
    BMC Ophthalmology publishes research on novel surgical methods and technologies, such as minimally invasive procedures and advanced lens implantation techniques, highlighting their impact on visual outcomes.
  3. Pathophysiology and Disease Mechanisms:
    The journal explores the underlying mechanisms of eye diseases, including genetic factors, inflammatory processes, and the role of environmental influences in the development and progression of ocular disorders.
  4. Public Health and Epidemiology:
    Research addressing the epidemiological aspects of eye diseases, including prevalence studies and risk factor analyses, is a core component, aiming to inform public health strategies and interventions.
  5. Advancements in Diagnostic Technologies:
    BMC Ophthalmology features studies on the latest diagnostic tools and imaging technologies, such as optical coherence tomography and angiography, that enhance the accuracy of disease detection and monitoring.
  6. Patient-Centered Outcomes and Quality of Life:
    The journal emphasizes the importance of patient-reported outcomes and quality of life assessments, ensuring that research reflects the perspectives and experiences of individuals affected by eye diseases.
BMC Ophthalmology is at the forefront of several emerging trends and themes in ophthalmic research. These trends reflect the evolving landscape of eye care, with a focus on innovative technologies, comprehensive treatment approaches, and patient-centered research.
  1. Artificial Intelligence in Ophthalmology:
    The integration of AI and machine learning techniques in diagnosing and predicting outcomes for ocular diseases is rapidly gaining traction, with studies exploring automated image analysis and predictive modeling.
  2. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated the adoption of telemedicine in ophthalmology, leading to an increase in research focused on remote patient monitoring, virtual consultations, and their effectiveness in managing eye diseases.
  3. Personalized Medicine Approaches:
    Emerging research emphasizes the tailoring of treatments based on individual patient characteristics, including genetic profiling and biomarker analysis, to optimize therapeutic outcomes.
  4. Regenerative Medicine and Stem Cell Therapy:
    There is a growing interest in regenerative approaches to treat ocular diseases, particularly in the context of stem cell therapy and tissue engineering for retinal and corneal repair.
  5. Comprehensive Management of Myopia:
    With the increasing prevalence of myopia globally, research is trending towards understanding its pathophysiology and developing effective management strategies, including orthokeratology and pharmacological interventions.

Declining or Waning

While BMC Ophthalmology continues to thrive in many areas of ophthalmic research, certain themes appear to be declining or waning in prominence. This can reflect shifts in research focus, technological advancements, or changes in clinical priorities within the field.
  1. Traditional Pharmacological Interventions:
    There is a noticeable decrease in studies focused solely on traditional pharmacological treatments for ocular diseases, as emphasis shifts towards combination therapies and innovative drug delivery systems.
  2. Outdated Surgical Techniques:
    Research centered on older surgical methods, such as traditional cataract extraction techniques, is becoming less frequent, with a growing focus on newer, less invasive approaches.
  3. Basic Science Studies with Limited Clinical Relevance:
    The journal has seen a reduction in basic science studies that do not directly translate to clinical applications, as the demand for clinically relevant research increases.
  4. Single-Center Studies:
    The prevalence of single-center studies appears to be decreasing, as larger, multi-center trials provide more robust data and generalizable findings.
  5. Non-Quantitative Assessments:
    There is a declining interest in qualitative studies lacking quantitative metrics, as researchers increasingly prioritize data-driven approaches that enhance reproducibility and statistical power.

Similar Journals

EXPERIMENTAL EYE RESEARCH

Shaping the Future of Ophthalmology with Groundbreaking Studies
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0014-4835Frequency: 12 issues/year

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

Ophthalmology Science

Leading the Way in Ophthalmic Innovation
Publisher: ELSEVIERISSN: 2666-9145Frequency:

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.

JAMA Ophthalmology

Catalyzing Change in the Field of Ophthalmology
Publisher: AMER MEDICAL ASSOCISSN: 2168-6165Frequency: 12 issues/year

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Expert Review of Ophthalmology

Delivering Critical Perspectives on Vision Science
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1746-9899Frequency: 6 issues/year

Expert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.

CURRENT EYE RESEARCH

Advancing the Frontiers of Ophthalmic Science
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Ophthalmology and Therapy

Connecting Researchers and Practitioners in Eye Care
Publisher: SPRINGER INT PUBL AGISSN: 2193-8245Frequency: 2 issues/year

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Journal of Ophthalmic & Vision Research

Illuminating Vision Science for Tomorrow
Publisher: KNOWLEDGE EISSN: 2008-2010Frequency: 4 issues/year

The Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Transforming Insights into Clinical Practices
Publisher: WILEYISSN: 1442-6404Frequency: 9 issues/year

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

CURRENT OPINION IN OPHTHALMOLOGY

Advancing the Frontiers of Eye Care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8738Frequency: 6 issues/year

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

Elevating the standards of ophthalmology through shared knowledge.
Publisher: CONSEL BRASIL OFTALMOLOGIAISSN: 0004-2749Frequency: 6 issues/year

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.